North America Hormonal Disorders Market Outlook to 2036 - Thyroid Function Tests

1.1 What Is This Report About?
1.2 Hormonal Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Hormonal Disorders Market, North America, Revenue ($m), 2024-2036
2.2 Hormonal Disorders Market, North America, Revenue ($m), 2024-2036
2.3 Hormonal Disorders Market, North America, Volume (Units), 2024-2036
2.4 Hormonal Disorders Market, North America, Volume (Units), 2024-2036
2.5 Hormonal Disorders Market, North America, Company Share by Revenue ($m), 2025

3.1 Hormonal Disorders Market, Canada, Revenue ($m), 2024-2036
3.1.1 Thyroid Function Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
3.2.1 Thyroid Function Tests Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Hormonal Disorders Market, Canada, Average Price ($), 2024-2036
3.4 Hormonal Disorders Market, Canada, Company Share by Revenue ($m), 2025

4.1 Hormonal Disorders Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Thyroid Function Tests Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Hormonal Disorders Market, Mexico, Volume (Units), 2024-2036
4.2.1 Thyroid Function Tests Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Hormonal Disorders Market, Mexico, Average Price ($), 2024-2036
4.4 Hormonal Disorders Market, Mexico, Company Share by Revenue ($m), 2025

5.1 Hormonal Disorders Market, United States, Revenue ($m), 2024-2036
5.1.1 Thyroid Function Tests Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Hormonal Disorders Market, United States, Volume (Units), 2024-2036
5.2.1 Thyroid Function Tests Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Hormonal Disorders Market, United States, Average Price ($), 2024-2036
5.4 Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2025

6.1 Hormonal Disorders Market Pipeline Products
6.2 Hormonal Disorders - Pipeline Products by Stage of Development
6.3 Hormonal Disorders - Pipeline Products by Segment
6.4 Hormonal Disorders - Pipeline Products by Territory
6.5 Hormonal Disorders - Pipeline Products by Regulatory Path
6.6 Hormonal Disorders - Pipeline Products by Estimated Approval Date

7.1 Siemens Healthineers AG
7.1.1 Company Overview
7.2 Beckman Coulter Inc
7.2.1 Company Overview
7.3 Roche Diagnostics International Ltd
7.3.1 Company Overview
7.4 Abbott Laboratories
7.4.1 Company Overview
7.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
7.5.1 Company Overview
7.6 Inova Diagnostics Inc
7.6.1 Company Overview

8.1 Corporate Communications
8.1.1 Nov 17, 2025: Fortrea Appoints Agnieszka Gallagher as General Counsel
8.1.2 Nov 14, 2025: COSCIENS Biopharma Announces Leadership Change
8.1.3 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
8.1.4 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.6 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
8.1.7 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
8.1.8 Oct 09, 2025: Abbott And Abbott Fund Support Northern Illinois Food Bank With $250,000 Grant To Address Childhood Hunger
8.2 Financial Announcements
8.2.1 Mar 25, 2026: COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
8.2.2 Jan 05, 2026: Abbott Hosts Conference Call for Fourth-Quarter Earnings
8.2.3 Nov 11, 2025: COSCIENS Biopharma Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
8.3 Government and Public Interest
8.3.1 Nov 25, 2025: Fortrea to Present at Citi and Evercore Healthcare Conferences
8.4 Other Significant Developments
8.4.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.4.2 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
8.5 Product News
8.5.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.5.2 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
8.5.3 Jul 16, 2025: Multicenter Trial Confirms Near-Infrared Autofluorescence Increases Detection of Parathyroid Glands
8.6 Strategy And Business Planning
8.6.1 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
8.6.2 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.6.3 Oct 29, 2025: EazeBio And UC Santa Cruz Form Strategic Partnership For Instrument-Free Diagnostics
8.6.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the Analyst Consulting
9.3 Contact Us
9.4 Disclaimer

Table 1: Hormonal Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Hormonal Disorders Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Hormonal Disorders Market, North America, Volume (Units), 2024-2036
Table 4: Hormonal Disorders Market, North America, Volume (Units), 2024-2036
Table 5: Hormonal Disorders Market, North America, Company Share by Revenue ($m), 2025
Table 6: Hormonal Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Thyroid Function Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
Table 9: Thyroid Function Tests Market, Canada, Volume (Units), 2024-2036
Table 10: Hormonal Disorders Market, Canada, Average Price ($), 2024-2036
Table 11: Hormonal Disorders Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 12: Hormonal Disorders Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 13: Thyroid Function Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 14: Hormonal Disorders Market, Mexico, Volume (Units), 2024-2036
Table 15: Thyroid Function Tests Market, Mexico, Volume (Units), 2024-2036
Table 16: Hormonal Disorders Market, Mexico, Average Price ($), 2024-2036
Table 17: Hormonal Disorders Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 18: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 19: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 20: Hormonal Disorders Market, United States, Volume (Units), 2024-2036
Table 21: Thyroid Function Tests Market, United States, Volume (Units), 2024-2036
Table 22: Hormonal Disorders Market, United States, Average Price ($), 2024-2036
Table 23: Hormonal Disorders Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 24: Hormonal Disorders Market Pipeline Products
Table 25: Hormonal Disorders - Pipeline Products by Stage of Development
Table 26: Hormonal Disorders Companies - Pipeline Products by Stage of Development
Table 27: Hormonal Disorders - Pipeline Products by Segment
Table 28: Hormonal Disorders - Pipeline Products by Territory
Table 29: Hormonal Disorders - Pipeline Products by Regulatory Path
Table 30: Hormonal Disorders - Pipeline Products by Estimated Approval Date
Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Hormonal Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hormonal Disorders Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hormonal Disorders Market, North America, Volume (Units), 2024-2036
Figure 4: Hormonal Disorders Market, North America, Volume (Units), 2024-2036
Figure 5: Hormonal Disorders Market, North America, Company Share (%), 2025
Figure 6: Hormonal Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Thyroid Function Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
Figure 9: Thyroid Function Tests Market, Canada, Volume (Units), 2024-2036
Figure 10: Hormonal Disorders Market, Canada, Company Share (%), 2025
Figure 11: Hormonal Disorders Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 12: Thyroid Function Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 13: Hormonal Disorders Market, Mexico, Volume (Units), 2024-2036
Figure 14: Thyroid Function Tests Market, Mexico, Volume (Units), 2024-2036
Figure 15: Hormonal Disorders Market, Mexico, Company Share (%), 2025
Figure 16: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 17: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 18: Hormonal Disorders Market, United States, Volume (Units), 2024-2036
Figure 19: Thyroid Function Tests Market, United States, Volume (Units), 2024-2036
Figure 20: Hormonal Disorders Market, United States, Company Share (%), 2025
Figure 21: Hormonal Disorders - Pipeline Products by Stage of Development
Figure 22: Hormonal Disorders - Pipeline Products by Segment
Figure 23: Hormonal Disorders - Pipeline Products by Territory
Figure 24: Hormonal Disorders - Pipeline Products by Regulatory Path
Figure 25: Hormonal Disorders - Pipeline Products by Estimated Approval Date